Stevanato Group S.p.A. (STVN) Stock Forecast, Price Target & Predictions
STVN Stock Forecast
Stevanato Group S.p.A. stock forecast is as follows: an average price target of $25.00 (represents a 18.93% upside from STVN’s last price of $21.02) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
STVN Price Target
The average price target for Stevanato Group S.p.A. (STVN) is $25.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $28.00 to $22.00. This represents a potential 18.93% upside from STVN's last price of $21.02.
STVN Analyst Ratings
According to 3 Wall Street analysts, Stevanato Group S.p.A.'s rating consensus is 'Buy'. The analyst rating breakdown for STVN stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Stevanato Group S.p.A. Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 07, 2024 | Patrick Donnelly | Citigroup | $28.00 | $19.87 | 40.92% | 33.21% |
| Jul 15, 2024 | Drew Ranieri | Morgan Stanley | $22.00 | $21.71 | 1.34% | 4.66% |
| Sep 26, 2023 | Jacob Johnson | Stephens | $33.00 | $27.07 | 21.91% | 56.99% |
| Jan 06, 2023 | Morgan Stanley | $22.00 | $19.84 | 10.86% | 4.66% | |
| Apr 25, 2022 | Wells Fargo | $19.00 | $16.59 | 14.53% | -9.61% |
The latest Stevanato Group S.p.A. stock forecast, released on Aug 07, 2024 by Patrick Donnelly from Citigroup, set a price target of $28.00, which represents a 40.92% increase from the stock price at the time of the forecast ($19.87), and a 33.21% increase from STVN last price ($21.02).
Stevanato Group S.p.A. Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $25.00 |
| Last Closing Price | $21.02 | $21.02 | $21.02 |
| Upside/Downside | -100.00% | -100.00% | 18.93% |
In the current month, the average price target of Stevanato Group S.p.A. stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Stevanato Group S.p.A.'s last price of $21.02. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 07, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 26, 2023 | Stephens | Overweight | Initialise | |
| Jul 31, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
| Jan 06, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Stevanato Group S.p.A.'s last stock rating was published by Citigroup on Aug 07, 2024. The company gave STVN a "Buy" rating, the same as its previous rate.
Stevanato Group S.p.A. Financial Forecast
Stevanato Group S.p.A. Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $237.99M | $292.10M | $245.26M | $234.25M | $212.07M | $232.57M | $214.53M | $203.96M |
| Avg Forecast | $410.25M | $363.25M | $341.31M | $306.73M | $364.17M | $314.76M | $290.67M | $263.34M | $337.88M | $305.48M | $273.05M | $255.91M | $360.76M | $296.37M | $273.31M | $253.70M | $290.99M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| High Forecast | $416.84M | $369.09M | $346.80M | $311.66M | $370.02M | $319.82M | $295.34M | $267.30M | $343.79M | $310.39M | $277.44M | $260.03M | $365.36M | $301.13M | $277.70M | $257.78M | $295.67M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| Low Forecast | $403.79M | $357.53M | $335.94M | $301.90M | $358.44M | $309.81M | $286.10M | $259.37M | $332.96M | $300.67M | $268.75M | $251.89M | $352.88M | $291.70M | $269.00M | $249.70M | $286.41M | $240.79M | $239.50M | $234.84M | $250.71M | $237.82M | $239.74M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.00% | 1.02% | 0.98% | 0.90% | 0.93% | 0.90% | 0.85% |
Stevanato Group S.p.A.'s average Quarter revenue forecast for Jun 23 based on 4 analysts is $273.31M, with a low forecast of $269.00M, and a high forecast of $277.70M. STVN's average Quarter revenue forecast represents a 14.84% increase compared to the company's last Quarter revenue of $237.99M (Mar 23).
Stevanato Group S.p.A. EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $59.21M | $70.90M | $64.42M | $59.88M | $53.31M | $59.86M | $41.76M | $61.55M |
| Avg Forecast | $99.71M | $88.29M | $82.96M | $74.55M | $88.51M | $76.50M | $70.65M | $64.00M | $82.12M | $74.25M | $66.37M | $62.20M | $87.68M | $72.03M | $66.43M | $61.66M | $70.73M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $39.79M |
| High Forecast | $101.31M | $89.71M | $84.29M | $75.75M | $89.93M | $77.73M | $71.78M | $64.97M | $83.56M | $75.44M | $67.43M | $63.20M | $88.80M | $73.19M | $67.49M | $62.65M | $71.86M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $47.75M |
| Low Forecast | $98.14M | $86.90M | $81.65M | $73.38M | $87.12M | $75.30M | $69.54M | $63.04M | $80.93M | $73.08M | $65.32M | $61.22M | $85.77M | $70.90M | $65.38M | $60.69M | $69.61M | $54.31M | $54.02M | $52.97M | $56.55M | $53.64M | $31.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 1.00% | 1.19% | 1.11% | 1.01% | 1.06% | 0.78% | 1.55% |
4 analysts predict STVN's average Quarter EBITDA for Jun 23 to be $66.43M, with a high of $67.49M and a low of $65.38M. This is 12.19% upper than Stevanato Group S.p.A.'s previous annual EBITDA (Mar 23) of $59.21M.
Stevanato Group S.p.A. Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.27M | $48.30M | $36.22M | $30.53M | $27.72M | $44.60M | $18.66M | $34.44M |
| Avg Forecast | $68.10M | $57.07M | $47.48M | $40.16M | $53.33M | $41.81M | $32.79M | $28.13M | $52.64M | $38.51M | $28.67M | $32.51M | $57.64M | $43.85M | $38.77M | $35.54M | $46.38M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $21.92M |
| High Forecast | $69.52M | $58.27M | $48.47M | $41.00M | $54.45M | $42.69M | $33.48M | $28.72M | $55.27M | $39.31M | $29.36M | $33.76M | $58.84M | $44.79M | $39.58M | $36.28M | $47.35M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $26.30M |
| Low Forecast | $66.71M | $55.90M | $46.51M | $39.34M | $52.24M | $40.96M | $32.12M | $25.78M | $50.01M | $37.72M | $27.99M | $31.27M | $54.90M | $42.91M | $37.97M | $34.81M | $45.43M | $35.41M | $33.30M | $30.31M | $31.61M | $30.01M | $17.53M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 1.04% | 1.02% | 0.92% | 0.91% | 1.41% | 0.62% | 1.57% |
Stevanato Group S.p.A.'s average Quarter net income forecast for Jun 23 is $38.77M, with a range of $37.97M to $39.58M. STVN's average Quarter net income forecast represents a 37.15% increase compared to the company's last Quarter net income of $28.27M (Mar 23).
Stevanato Group S.p.A. SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.27M | $33.20M | $25.82M | $29.35M | $23.42M | $22.25M | $29.37M | $11.45M |
| Avg Forecast | $47.53M | $42.08M | $39.54M | $35.54M | $42.19M | $36.47M | $33.68M | $30.51M | $39.14M | $35.39M | $31.63M | $29.65M | $41.79M | $34.33M | $31.66M | $29.39M | $33.71M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $7.29M |
| High Forecast | $48.29M | $42.76M | $40.18M | $36.11M | $42.87M | $37.05M | $34.22M | $30.97M | $39.83M | $35.96M | $32.14M | $30.13M | $42.33M | $34.89M | $32.17M | $29.86M | $34.25M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $8.75M |
| Low Forecast | $46.78M | $41.42M | $38.92M | $34.98M | $41.53M | $35.89M | $33.14M | $30.05M | $38.57M | $34.83M | $31.14M | $29.18M | $40.88M | $33.79M | $31.16M | $28.93M | $33.18M | $27.48M | $27.34M | $26.80M | $28.62M | $27.14M | $5.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.98% | 0.94% | 1.07% | 0.87% | 0.78% | 1.08% | 1.57% |
Stevanato Group S.p.A.'s average Quarter SG&A projection for Jun 23 is $31.66M, based on 4 Wall Street analysts, with a range of $31.16M to $32.17M. The forecast indicates a 11.99% rise compared to STVN last annual SG&A of $28.27M (Mar 23).
Stevanato Group S.p.A. EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 6 | 3 | 3 | 3 | 6 | 4 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.11 | $0.18 | $0.14 | $0.12 | $0.10 | $0.17 | $0.07 | $0.11 |
| Avg Forecast | $0.25 | $0.21 | $0.17 | $0.15 | $0.20 | $0.15 | $0.12 | $0.10 | $0.19 | $0.14 | $0.11 | $0.12 | $0.21 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| High Forecast | $0.25 | $0.21 | $0.18 | $0.15 | $0.20 | $0.16 | $0.12 | $0.11 | $0.20 | $0.14 | $0.11 | $0.12 | $0.22 | $0.16 | $0.15 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| Low Forecast | $0.24 | $0.20 | $0.17 | $0.14 | $0.19 | $0.15 | $0.12 | $0.09 | $0.18 | $0.14 | $0.10 | $0.11 | $0.20 | $0.16 | $0.14 | $0.13 | $0.17 | $0.13 | $0.12 | $0.11 | $0.12 | $0.11 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.84% | 1.06% | 1.08% | 0.98% | 0.90% | 1.47% | 0.64% | 0.74% |
According to 4 Wall Street analysts, Stevanato Group S.p.A.'s projected average Quarter EPS for Jun 23 is $0.14, with a low estimate of $0.14 and a high estimate of $0.15. This represents a 29.15% increase compared to STVN previous annual EPS of $0.11 (Mar 23).
Stevanato Group S.p.A. Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AKYA | Akoya Biosciences | $2.54 | $4.83 | 90.16% | Buy |
| XRAY | DENTSPLY SIRONA | $19.19 | $29.50 | 53.73% | Hold |
| TFX | Teleflex | $178.28 | $254.50 | 42.75% | Buy |
| ANGO | AngioDynamics | $9.26 | $13.00 | 40.39% | Buy |
| HAE | Haemonetics | $82.07 | $107.00 | 30.38% | Buy |
| ATRC | AtriCure | $31.50 | $39.67 | 25.94% | Buy |
| ATR | AptarGroup | $163.09 | $200.00 | 22.63% | Buy |
| COO | Cooper Companies | $94.49 | $115.00 | 21.71% | Buy |
| ALC | Alcon | $85.54 | $104.00 | 21.58% | Buy |
| ICUI | ICU Medical | $157.17 | $190.50 | 21.21% | Buy |
| WST | West Pharmaceutical Services | $334.26 | $393.00 | 17.57% | Buy |
| MMSI | Merit Medical Systems | $99.00 | $108.83 | 9.93% | Buy |
| STVN | Stevanato Group S.p.A. | $23.67 | $25.00 | 5.62% | Buy |
| NVST | Envista | $19.24 | $20.29 | 5.46% | Hold |
| RMD | ResMed | $242.62 | $233.50 | -3.76% | Hold |